Transvenous leads are the most common source of complications associated with the use of implantable cardioverter-defibrillators (ICDs). A preliminary experience with an entirely subcutaneous ICD ...

Please provide your email address to receive an email when new articles are posted on . A subcutaneous implantable cardioverter defibrillator was noninferior to a transvenous ICD regarding major ...

Please provide your email address to receive an email when new articles are posted on . An entirely subcutaneous implantable cardioverter defibrillator system was found to successfully and ...

NICE, FRANCE – A longer-term assessment of a new subcutaneous implantable cardioverter defibrillator (ICD) (Boston Scientific) shows that just over 90% of patients are free from complications at two ...

In a typical population of patients requiring implantable cardioverter-defibrillator (ICD) therapy without pacing, mostly for the primary prevention of sudden cardiac death, a subcutaneous ICD (S-ICD; ...

Though the PRAETORIAN group was technically unable to prove that 8 years was enough to give a subcutaneous implantable cardioverter-defibrillator (ICD) an edge in safety, complication rates helped ...

Last year the FDA approved Boston Scientific's subcutaneous ICD, the first ICD that can defibrillate the heart without using leads threaded to the heart through the blood vessels. Those leads are the ...

Boston Scientific's Emblem S-ICD, the next generation subcutaneous ICD product, is a novel technology that removes what many believe is the weakest link in implantable cardioverter defibrillators - ...

Years ago, during training, I remember a colleague dissing an early model of an implantable cardioverter-defibrillator (ICD) because it was primitive. All it did was shock ventricular tachycardia (VT) ...

The FDA’s Circulatory System Devices panel voted 7-1 on Thursday that the benefits of the Cameron Health subcutaneous ICD system (S-ICD) outweigh the risks in appropriately selected patients. The ...

Implantable cardioverter–defibrillators (ICDs) prevent sudden death from cardiac causes in selected patients but require the use of transvenous lead systems. To eliminate the need for venous access, ...